Deficient nucleotide excision repair capacity enhances human prostate cancer risk
about
Single nucleotide polymorphisms in DNA repair genes and prostate cancer riskThe effect of XPD polymorphisms on digestive tract cancers risk: a meta-analysisNo association between variant DNA repair genes and prostate cancer risk among men of African descent.A rapid assay for measuring nucleotide excision repair by oligonucleotide retrieval.Genetic variation in DNA repair genes and prostate cancer risk: results from a population-based studyPolycyclic aromatic hydrocarbon--DNA adducts in prostate and biochemical recurrence after prostatectomyThe association of DNA Repair with breast cancer risk in women. A comparative observational studyDNA damage phenotype and prostate cancer risk.Role of hormonal and other factors in human prostate cancer.XPD Lys751Gln polymorphism and esophageal cancer risk: a meta-analysis involving 2288 cases and 4096 controls.Polymorphisms of the NER pathway genes, ERCC1 and XPD are associated with esophageal adenocarcinoma risk.DNA repair phenotype and cancer susceptibility--a mini review.Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis.Genetic variation in nucleotide excision repair pathway genes, pesticide exposure and prostate cancer risk.DNA repair capacity of zebrafish.Estrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer.DNA repair capacity, DNA-strand break repair gene polymorphisms, and the incidence of hepatocellular carcinoma in southwestern Guangxi of China.Deficiency of DNA repair nuclease ERCC1-XPF promotes prostate cancer progression in a tissue recombination model.Elevated polycyclic aromatic hydrocarbon-DNA adducts in benign prostate and risk of prostate cancer in African Americans.Genotypes and haplotypes of ERCC1 and ERCC2/XPD genes predict levels of benzo[a]pyrene diol epoxide-induced DNA adducts in cultured primary lymphocytes from healthy individuals: a genotype-phenotype correlation analysis.Cancer incidence among pesticide applicators exposed to butylate in the Agricultural Health Study (AHS).Cytokine genetic polymorphisms and prostate cancer aggressivenessProstate cancer risk associated loci in African Americans.Assays to determine DNA repair ability.Xeroderma pigmentosum group D polymorphisms and esophageal cancer susceptibility: a meta-analysis based on case-control studies.Towards precision prevention: Technologies for identifying healthy individuals with high risk of disease.Seleno-L-Methionine Modulation of Nucleotide Excision DNA Repair Relevant to Cancer Prevention and Chemotherapy.Radiosensitivity and repair kinetics of gamma-irradiated leukocytes from sporadic prostate cancer patients and healthy individuals assessed by alkaline comet assay.Lack of association between XPD Lys751Gln and Asp312Asn polymorphisms and colorectal cancer risk: a meta-analysis of case-control studies.Intake of plant foods and associated nutrients in prostate cancer risk.MUTYH Tyr165Cys, OGG1 Ser326Cys and XPD Lys751Gln polymorphisms and head neck cancer susceptibility: a case control study.Impact of XPD gene polymorphism on risk of prostate cancer on north Indian population.
P2860
Q28383002-10FC9692-DF5A-4DF5-B5DD-081716E1975EQ33560417-A1052878-80C2-4CC1-A75D-549B68665E8EQ33560632-FCC0D292-7F93-4A30-B8A4-DC1E53D211C9Q33581729-2E6E17CC-B9FD-48A0-83E0-92AB1356874FQ33609681-7EA428F6-61CD-4B4F-82EE-4DED7368FBFFQ33641222-030DBAF7-9092-4D94-A173-9F69787BF829Q34454257-D3CA85F3-1F80-4ADC-9811-B1EE261805CEQ34572342-16EC1C17-ECF2-4989-BEC7-87EDF9429D92Q34764764-3AC6EC6B-9271-4F30-B0D9-331FE5B903A6Q34993715-2B9E2053-4E73-4F89-B35A-849FAC55491BQ35019371-242059C7-FD1C-4BC6-9CC0-D6DEC8E3A027Q35146743-DB838DDE-ED7E-461A-AFF0-551FCC5CC3FCQ35567486-3E5EFE9E-05E0-4F4A-93E3-5F25E885FFF3Q35730592-8EED5DCE-0C56-4516-809C-0CB38D6D5777Q35941386-F8087E24-430F-4C82-BCC6-D52A64340170Q35975638-5281AF3B-0F41-4D33-A809-293F7960E043Q36118118-F71A5EEE-D590-4FD7-9CA5-51D466FE0D83Q36375461-B7FFEE38-5BEF-4F61-A54A-CFA12177CF15Q36499803-04CDBC5B-41BB-4E3A-8F74-A17F9D5B21B3Q36837999-9BDF2BEF-3041-4A99-8E42-44230D7F1E26Q37238089-349CBF68-64EF-4EB6-BFC5-4DB879EE6C68Q37281675-FBCDF001-6C0F-454A-9092-8E4557D78EBFQ37312769-8C9FB750-E7C4-4378-8C0C-4499675EE5E5Q37894725-8D12E998-64E3-4A6B-B3ED-C57C44281752Q38282078-6F9616AA-39F3-4B08-B066-2B374F99064BQ38811931-A2824B73-92EC-423A-BDE1-46903E9FEC6BQ39774340-472FD062-0E24-48B2-BE87-33F9CFB2D6EEQ41894983-0A7D2DBB-F7FD-427B-A0DA-02F3DDED4A7DQ44690550-42B0DFE8-EC34-412A-97B1-E4FA61F8A2DDQ46113402-EC990D0E-FF59-4D3E-841E-86614404648BQ46669766-736FB934-D955-40F4-A5D0-EB78F36809B0Q54337194-97B28993-F66A-4240-8189-C46DA399F790
P2860
Deficient nucleotide excision repair capacity enhances human prostate cancer risk
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Deficient Nucleotide Excision Repair Capacity Enhances Human Prostate Cancer Risk
@nl
Deficient nucleotide excision repair capacity enhances human prostate cancer risk
@ast
Deficient nucleotide excision repair capacity enhances human prostate cancer risk
@en
Deficient nucleotide excision repair capacity enhances human prostate cancer risk
@en-gb
type
label
Deficient Nucleotide Excision Repair Capacity Enhances Human Prostate Cancer Risk
@nl
Deficient nucleotide excision repair capacity enhances human prostate cancer risk
@ast
Deficient nucleotide excision repair capacity enhances human prostate cancer risk
@en
Deficient nucleotide excision repair capacity enhances human prostate cancer risk
@en-gb
prefLabel
Deficient Nucleotide Excision Repair Capacity Enhances Human Prostate Cancer Risk
@nl
Deficient nucleotide excision repair capacity enhances human prostate cancer risk
@ast
Deficient nucleotide excision repair capacity enhances human prostate cancer risk
@en
Deficient nucleotide excision repair capacity enhances human prostate cancer risk
@en-gb
P921
P3181
P1433
P1476
Deficient nucleotide excision repair capacity enhances human prostate cancer risk
@en
P2093
P2880
P304
P3181
P356
10.1158/0008-5472.CAN-03-2670
P407
P577
2004-02-01T00:00:00Z